CBIO stock pitch - 2018-09-14

Added to YB: 2018-09-14

Pitch date: 2018-09-14

Catalyst Biosciences, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

As of October 30, 2023, Catalyst Biosciences, Inc. was acquired by Beijing Continent Pharmaceutical Co.

Market Cap

$19.4M

Pitch Price

$22.97

Price Target

N/A

Dividend

N/A

EV/EBITDA

-3.73

P/E

-0.42

EV/Sales

N/A

Sector

Biotechnology

A summary for this pitch has not been created yet.